
Thank you @SaadAtiq24 and #DAVAGU. We definitely encourage all investigators to enroll to @SWOG S2419 BioFront , the very first registrational trial to harness the #microbiome for patients with #RCC! Early trials of the MO-03 probiotic showed strong efficacy signals without added toxicity. Many thanks to @PBarataMD @drulkav @montypal @NazliDizman @djmcconkey @LauraEsfeller for leading this effort to help patients with kidney cancer.
























